- Profile
- Personal Information
- Publications
Experts in Clinical Sciences
Natasha Anandaraj Mark White Susan K Birden MICHAEL BILL Pravir Kumar Roger Badia P.Madhava Soma Sundaram Douglas K. Martin Blaine Y. Takesue Karsten Rebner JEFF ANDERSON Syed Umarhathab R.Sivakumar Enanalap Periyar Amy Berkov Kristin Meyer Nora Stelter A.J.R. Albert Heck Simon Allison BIG ANNA MARIA View MoreBiography
Ofer Goldberg is the CTO of Clal Biotechnology industries (TASE: CBI) and the managing director of Anatomy Medical Technology Fund. Over the past fifteen years, Mr. Goldberg is actively involved with healthcare related companies ranging in stage from inception to commercialization. Mr. Goldberg serves as a board member in several biotech and medical device companies, including Biocancell (TASE: BNCL), Curetech, Pi-Cardia, Cologuard and SightDX. Mr. Goldberg holds an M.A. in Economics and Finance from Tel Aviv University and a B.Sc. in Physics and Mathematics from the Hebrew University of Jerusalem.
Research Intrest
Healthcare